検索キーワード： 身体的病い・疾患

Host Julia Cartwright investigates how GLP-1 medications—originally created for diabetes and weight loss—may revolutionize treatment for polycystic ovary syndrome by targeting insulin resistance, restoring hormonal balance, and offering new hope for fertility. Each episode examines the science, patient experiences, and critical gaps in research shaping this emerging therapeutic frontier. For more content like this, visit QuietPlease.ai

Dr. Ben Synth investigates why Ozempic keeps disappearing from pharmacies despite explosive demand. This series explores the supply chain crisis triggered by 442% prescription growth, the dangerous counterfeit market filling the gaps, and Novo Nordisk's massive $16 billion manufacturing expansion racing to catch up. For more content like this, visit QuietPlease.ai

Guru Anand Bodhi dissects the science behind Ozempic's hormone hijacking versus intermittent fasting's metabolic rewiring, examining which method delivers lasting weight loss. From appetite suppression mechanisms to rebound risks and hidden side effects, discover the real trade-offs between pharmaceutical intervention and lifestyle discipline. For more content like this, visit QuietPlease.ai

Host Julia Cartwright explores why GLP-1 medications have surged among women navigating perimenopause and menopause. Each episode unpacks clinical trial data, safety concerns, and surprising benefits beyond weight loss—from hormone interactions to metabolic changes—helping women over 40 make evidence-based decisions about these drugs. For more content like this, visit QuietPlease.ai

When bariatric surgery doesn't maintain weight loss long-term, can Ozempic fill the gap—or does stacking two powerful interventions create dangerous new risks? Dr. Ben Synth unpacks the clinical evidence, patient outcomes, and medical debate surrounding this controversial weight-loss combination. For more content like this, visit QuietPlease.ai

A compelling vodcast that brings together the voices that matter most in the cancer journey—patients and physicians. Sponsored by the Arizona Center for Cancer Care, this series offers an honest, insightful look at what comes after a cancer diagnosis. Each episode features thoughtful conversations that bridge clinical expertise with lived experience, exploring treatment decisions, emotional realities, survivorship, and the evolving landscape of cancer care.

Welcome to Hope in a Dose—the podcast where we explore the science, strategy, and stories behind the therapies redefining what’s possible. Designed for CGT innovators, this series helps you move smarter, faster, and with greater operational confidence. Across each episode, we unpack the real-world challenges sponsors face today: selecting truly CGT-capable sites, navigating early-phase risk, activating global trials in rare populations, and demonstrating meaningful clinical impact. Hosted by Lousie Kearney Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea, a seasoned leader ...

Miss Olivia Harper investigates whether GLP-1 drugs like Ozempic and Wegovy belong in pediatric medicine, exploring clinical trial data, doctor perspectives, and the real-world stakes for teens navigating obesity, identity, and a treatment with unknown long-term effects. For more content like this, visit QuietPlease.ai

Clare Delish delivers practical, science-backed eating strategies for anyone on Ozempic or GLP-1 medications. Learn how to maximize nutrition when your appetite shrinks, protect your muscle mass with smart protein choices, and minimize side effects through strategic meal planning that actually tastes good. For more content like this, visit QuietPlease.ai

Discover why rapid weight loss from GLP-1 medications like Ozempic can lead to dramatic facial aging. Julia Cartwright explores the science of facial fat loss, the cosmetic treatments racing to reverse it, and who's most at risk for this unexpected side effect. For more content like this, visit QuietPlease.ai

Neste podcast, Marco Negreiros — médico oftalmologista, CEO da Eyecare Health e apaixonado por inovação — recebe convidados e compartilha visões sobre tudo o que move a saúde visual no Brasil e no mundo.Entre diagnósticos, tecnologias, startups e gestão, aqui cabem histórias reais, aprendizados de bastidor e reflexões que atravessam a oftalmologia, o empreendedorismo e o futuro da medicina.Se você é médico, gestor, curioso ou visionário: pode chegar.Esse é o podcast para quem quer enxergar mais longe.

Benvenuti su Retina On-Air, lo spazio editoriale audio ufficiale della GIVRE (Gruppo Italiano di Chirurgia Vitreoretinica). In un mondo medico che corre alla velocità della luce, questo podcast nasce per fermare il tempo e dare voce all'eccellenza dell'oftalmologia italiana.Il FormatCondotto dal Prof. Rodolfo Mastropasqua e dal Dr. Ruggero Tartaro, il podcast ospita i più illustri chirurghi vitreoretinici per un dialogo che va oltre la semplice letteratura scientifica. Ogni episodio è un’immersione profonda nella carriera e nella mente dei grandi maestri, analizzando il binomio ...

Maxwell Slate investigates bombshell claims that Trump made false statements disconnected from reality during cabinet meetings, separating lies from possible memory failure. Through clinical analysis of confabulation, fact-checker documentation, and ethical debates over remote diagnosis, the series asks whether fiction in the Cabinet Room signals deliberate deception or something far more troubling. For more content like this, visit QuietPlease.ai

This is the Inquisitive Vet. A podcast where we explore all aspects of Exotic medicine and surgery. In each episode, listeners will learn from a veterinary leader and mentor at the forefront of Exotic medicine and technology today. Find out more at inquisitivevet.com

Dr. Ben Synth reveals why up to 15% of patients see little benefit from Ozempic and similar GLP-1 medications, exploring genetic factors, gut microbiome differences, and real-world adherence challenges. Discover the cutting-edge science explaining who responds to these blockbuster weight-loss drugs and who doesn't. For more content like this, visit QuietPlease.ai

This podcast is hosted by two passionate pediatric urologists, Dr. Albert and Dr. Mike, who explore and discuss various pediatric urological conditions through honest conversations. Contents are educational in nature and should not be considered medical advice

À travers des témoignages de terrain, des cas cliniques, des échanges sincères et des conseils pratiques, nous vous aidons à mieux comprendre vos animaux, leurs besoins, leur santé et les situations que vous pouvez rencontrer au quotidien. Ce podcast vous ouvre les portes de la médecine vétérinaire telle qu’elle se vit vraiment dans les cliniques du groupe ANIBIO : des histoires vraies, des expériences marquantes, des réflexions de professionnels, mais aussi des explications accessibles pour répondre aux questions que se posent de nombreux propriétaires. Pourquoi votre animal ...

Discover the life and career of Mike Sicilia, one of the most influential executives in enterprise technology, healthcare innovation, and artificial intelligence, on Mike Sicilia - Biography Flash. Hosted by AI host Vanessa Clark, this podcast delivers an in-depth biography of the Oracle executive who oversees industry-specific cloud solutions and AI-powered applications across healthcare, life sciences, retail, financial services, hospitality, energy, local government, and more. From his computer science education at Saint Joseph's University in Philadelphia to his roots at Primavera Systems ...

Das ZFM - Zentrum für Mobilität, eine Praxisgemeinschaft aus Ärzten und medizinischen Dienstleistern, informiert Sie zu aktuellen Themen des Bewegungsapparates.Dr. Johannes Gruendler, Facharzt für Othopädie und orthopädische Chirurgie, führt durch die Podcast-Serie, welche Blog-Artikel unserer Ärzte und Therapeuten im ZFM zur Grundlage hat.Diese wurden mittels KI in ein kritisch-hinterfragendes Zwiegespräch zweier KI-Charaktere umgewandelt .Viel Vergnügen beim Hineinhören !

Discover why the identical molecule semaglutide exists as two blockbuster drugs with different names, doses, and purposes. Julia Cartwright demystifies Ozempic and Wegovy, revealing the FDA approvals, dosing strategies, insurance battles, and clinical evidence that separate diabetes treatment from weight management. For more content like this, visit QuietPlease.ai